BioPharmaceutical

Related by string. biopharmaceutical * * Nabi Biopharmaceuticals leverages . commercializes innovative biopharmaceuticals . specialty biopharmaceutical . Nabi Biopharmaceuticals . Alder Biopharmaceuticals . Alder Biopharmaceuticals Inc. . Nasdaq ACAD biopharmaceutical . Inspiration Biopharmaceuticals . Keryx Biopharmaceuticals Inc. . Keryx Biopharmaceuticals KERX *

Related by context. Frequent words. (Click for all words.) 66 Strengthens Leadership 65 Achieves Milestone 65 Develop Next Generation 64 Announces FDA Clearance 64 Develop Novel 63 Introduces Enhanced 63 Awarded Patent 62 Announces Immediate Availability 61 Deliver Comprehensive 61 Provides Comprehensive 61 Increase Efficiency 61 Introduces Next Generation 61 FDA Clears 61 Bioprocess 60 Announces Organizational Changes 60 Introduces Innovative 60 Deliver Enhanced 60 Provide Enhanced 60 Announces Enhancements 60 Bio Pharmaceutical 60 Seamless Integration 60 Announce Availability 60 Releases Enhanced 59 Realigns 59 Launches Unique 59 Deliver Integrated 59 Receives Patent 59 Receives Recognition 59 Introduces Revolutionary 59 Pharma Biotech 59 Strengthens Its 59 Provide Comprehensive 59 Announce Collaboration 59 Expand Relationship 59 Unveils Next Generation 59 Inc Therapeutic Competitors 59 Reduces Costs 59 Further Strengthens 59 Announces Additions 59 Helps Businesses 59 Renews Agreement 59 Receives FDA Clearance 58 Spins Off 58 Signs Licensing Agreement 58 Patent Issued 58 Lowers Guidance 58 Signs Agreements 58 Finalizes Acquisition 58 Extends Reach 58 Attains Gold Certified Partner 58 Launches Enhanced 58 Delivers Enhanced 58 Significantly Improves 58 Increase Productivity 58 Announce Merger 58 Enters Strategic 57 Reduces Risk 57 Small Molecule 57 Complete Merger 57 Deliver Next Generation 57 Launches Next Generation 57 Formalizes 57 Extends Leadership 57 Secures Financing 57 Report Analyzes 57 Unveils Innovative 57 Host Webinar 57 Extends Relationship 57 Injection Molding 57 Single Dose 57 Q2 Profit Surges 57 Expands Reach 57 RNAi Therapeutics 57 Introducing Leading Microcap 56 Reports Profitable 56 Significantly Reduces 56 CFO Resigns 56 Exhibitor Profiles 56 Innovative Approach 56 Secures Funding 56 4Q Profit Jumps 56 Announces Definitive Agreement 56 Improve Quality 56 ARM Embedded 56 Schedules Fiscal 56 Organizational Changes 56 Solution Enables 56 Study Demonstrates 55 Fifth Consecutive Year 55 Cuts Costs 55 RNA Interference 55 Expands Relationship 55 Patient Enrollment 55 Solution Helps 55 Awarded Multi 55 Preclinical Data 55 Stockholders Approve Merger 55 Awarded Prestigious 55 Client Roster 55 Innovates 55 Director Exercises Options

Back to home page